You are here

layoffs

DBV restructuring claims 200 jobs as it beats out a path toward peanut patch OK

DBV restructuring claims 200 jobs as it beats out a path toward peanut patch OK

Endpoints

DBV Technologies

Flag link:

Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program

Autolus buckles down, chopping 20% of staff and seeking partner for a lead CAR-T program

Endpoints

Autolus Therapeutics

diffuse large B-cell lymphoma

Flag link:

Calithera flunks phase 2 cancer trial, axes 35% of staff

Calithera flunks phase 2 cancer trial, axes 35% of staff

Fierce Biotech

Calithera Biosciences

clinical trials

renal cell carcinoma

Flag link:

Savara says sayonara to pipeline programs, doubles down on Molgradex, cuts staff

Savara says sayonara to pipeline programs, doubles down on Molgradex, cuts staff

Fierce Biotech

cystic fibrosis

Flag link:

Boston Scientific's Lotus Retirement Spells Job Loss

Boston Scientific's Lotus Retirement Spells Job Loss

Medical Devices and Diagnostics Industry

Boston Scientific

Flag link:

Endo to cut 560 staffers, shutter drug plants to save cash for spring cellulite launch

Endo to cut 560 staffers, shutter drug plants to save cash for spring cellulite launch

Fierce Pharma

Flag link:

Santhera axes half its employees and sees CMO depart after PhIII DMD fail

Santhera axes half its employees and sees CMO depart after PhIII DMD fail

Endpoints

Duchenne Muscular Dystrophy

Flag link:

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Sanofi, intent on slimming down, mulls $200M-plus sale of anti-inflammation meds: report

Fierce Pharma

Flag link:

Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries

Genfit Restructuring Cuts Staff by 40%, Creates Two New Subsidiaries

Xconomy

Flag link:

Ironwood puts GERD hopeful on the chopping block, along with 100 staffers after flop

Ironwood puts GERD hopeful on the chopping block, along with 100 staffers after flop

Fierce Biotech

Ironwood Pharmaceuticals

Flag link:

Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25%

Reeling From FDA Rejection, Intercept Pharma Slashes Headcount by 25%

Xconomy

Intercept Pharma

Flag link:

Teva, on the heels of major reorg, plans to cut 350 more manufacturing jobs in Israel

Teva, on the heels of major reorg, plans to cut 350 more manufacturing jobs in Israel

Fierce Pharma

Teva Pharmaceutical

drug manufacturing

Flag link:

Genentech to eliminate 474 positions

Genentech to eliminate 474 positions

Beckers Hospital Review

Flag link:

Philadelphia generic drugmaker slashes workforce by 8.5% after competitor emerges

Philadelphia generic drugmaker slashes workforce by 8.5% after competitor emerges

Beckers Hospital Review

Flag link:

With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash

With Peanut Patch in FDA Purgatory, DBV Plans Layoffs to Stretch Cash

Xconomy

DBV Technologies

Flag link:

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

Sanofi Considering Additional Restructuring and Up to 1,000 Job Cuts

BioSpace

Flag link:

Lundbeck plotting up to 160 R&D job cuts as it rebuilds pipeline

Lundbeck plotting up to 160 R&D job cuts as it rebuilds pipeline

Fierce Biotech

Flag link:

Pharma layoffs slow as companies respond to COVID-19 pandemic

Pharma layoffs slow as companies respond to COVID-19 pandemic

Beckers Hospital Review

pharma industry

Flag link:

AMAG Pharma to Lay Off 140 Staffers as Part of Company Restructure

AMAG Pharma to Lay Off 140 Staffers as Part of Company Restructure

BioSpace

Amag Pharmaceuticals

Flag link:

Orchard lays off a quarter of its staff amid major shift

Orchard lays off a quarter of its staff amid major shift

BioPharma Dive

Orchard Therapeutics

Flag link:

Pages